Article

Novel CRISPR-Cas9 BAP1 Knockout Pre-Clinical Tumor Model Recapitulates Human Melanoma Tumorigenesis and Immune Evolution

2025-04-09

Abstract excerpt

<title>Abstract</title> <p>BAP1-deficient melanocytic tumors exhibit strong immunosuppressive features and poor prognosis. Currently, no immune-competent preclinical models exist to study their tumor-immune interactions or test new immunotherapies. This limitation hinders progress in understanding how BAP1 loss drives tumor aggressiveness and immune evasion. To address this, we generated a syngeneic BAP1 knockout...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e511e589-a37d-52f9-9bfc-fbca13f989a5
DOI: 10.21203/rs.3.rs-6134890/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Novel CRISPR-Cas9 BAP1 Knockout Pre-Clinical Tumor Model Recapitulates Human Melanoma Tumorigenesis and Immune EvolutionDOI 10.21203/rs.3.rs-6134890/v1Read

Novel CRISPR-Cas9 BAP1 Knockout Pre-Clinical Tumor Model Recapitulates Human Melanoma Tumorigenesis and Immune EvolutionSemantic proximity Read

BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Up-Regulation of PROS1 in Class 2 Uveal MelanomasSemantic proximity Read

BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal MelanomasSemantic proximity Read

A Multistep Immune-Competent Genetically Engineered Mouse Model Reveals Phenotypic Plasticity in Uveal Melanoma.Semantic proximity Read

A multi-step immune-competent genetic mouse model reveals phenotypic plasticity in uveal melanomaSemantic proximity Read

GNAQ Induces Melanomagenesis in Mitfa-Independent Melanocyte Progenitors in a Zebrafish Model of Uveal MelanomaSemantic proximity Read

Exploring the Complex and Multifaceted Interplay between Melanoma Cells and the Tumor MicroenvironmentSemantic proximity Read

The landscape of gain and loss of function mutations in melanomaSemantic proximity Read

Multi-model preclinical platform predicts clinical response of melanoma to immunotherapySemantic proximity Read

Dynamic changes of genomic and transcriptomic tumor diversity during melanoma progressionSemantic proximity Read

Metabolic Alterations and Therapeutic Opportunities in Rare Forms of Melanoma.Semantic proximity Read

Advances in immunotherapy for uveal melanoma: enhancing efficacy and overcoming resistanceSemantic proximity Read